CUV fundamentals
CLINUVEL PHARMACEUTICALS LIMITED earnings per share and revenue
CUV earnings per share for the last semiannual are 0.28 AUD whereas the estimation was 0.22 AUD which accounts for 29.03% surprise. Company revenue for the same period amounts to 35.65 M AUD despite the estimated figure of 34.71 M AUD. Estimated earnings per share for the next semiannual are 0.38 AUD, and revenue is expected to reach 62.03 M AUD. Also watch annual changes over time to get a bigger picture of CUV earnings per share and revenue dynamics.
Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise